SEHK:9969Biotechs
A Look At InnoCare Pharma (SEHK:9969) Valuation As It Targets First Profit On 2025 Revenue Growth
InnoCare Pharma (SEHK:9969) is back in focus after the company projected an improvement in its 2025 financial performance, supported by stronger drug sales and an anticipated move into profitability for the first time.
See our latest analysis for InnoCare Pharma.
That profit outlook comes after a mixed share price run, with the latest close at HK$11.72. The 1 year total shareholder return of 111.93% contrasts with a 5 year total shareholder return decline of 44.06%. This suggests recent...